Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to eyeball08,Wondergirly,bofh,johnstevens77,Bhoddhisatva, for Donating to support the site

MrC's Smallcap Sweeps for Jan 2020

Discuss Stock buying Shares, tips and ideas for stock market dealing
MrContrarian
Lemon Quarter
Posts: 1778
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1611 times

Re: MrC's Smallcap Sweeps for Jan 2020

#279571

Postby MrContrarian » January 24th, 2020, 7:34 am

Smallcap Sweep. 24-Jan-20
SQN anaerobic indigestion.

Norman Broadbent (NBB) FY trading: rev up 22% (H1 up 13%). Pretax £16k (-£265k). No F/C or guidance re mgmt expectations.
GETECH (GTC) warns FY rev only £6m (£8m). EBITDA £0.6-0.8m (£1.1m). Says negotiations on several substantial transactions overran. Working to reduce lumpiness of orders.
Hansard Global (HSD) Q2 new business up 7%, down from 10% in Q1. Co is "pleased to have built further upon our strong start to the financial year." If you say so.
SQN Asset Finance Income Fund (SQN) strategic review of the Company's operations as it deays NAV figure Anaerobic Digestion assets are revalued. Previously cited poor performance of these assets.
Tekcapital (TEK) wins 'major' food contract for to assist in the sale of Microsalt to snack food companies in the southwestern US. Burps up some MBA naff cliches: "Our partnership is a win-win-win as we are offering their customers a unique, on-trend, innovative ingredient."

In line: RBG, RTC

Notes (do not rely on the data)
NBB: Price=8. Cap=4m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Norman Broadbent is a provider of Talent Acquisition and Advisory Services, consisting of board and executive search, senior interim management, leadership consulting and assessment, and mezzanine level search.
GTC: Price=25. Cap=10m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
GETECH Group is the UK-based geosciences service provider company. It is primarily engaged in the provision of geological services, reports and data to the petroleum and mining industries to assist in their exploration activities.
HSD: Price=42.7. Cap=59m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Hansard Global is a specialist long-term savings provider. It is engaged in distribution and servicing of long-term investment products. The company's products comprise of Vantage Platinum II, Capital Builder Family and Universal Personal Portfolio.
SQN: Price=63. Cap=336m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
TEK: Price=6.25. Cap=4m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Tekcapital is a technology and intellectual property services company. It assists its clients to innovate faster and to protect core products and services.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1778
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1611 times

Re: MrC's Smallcap Sweeps for Jan 2020

#280205

Postby MrContrarian » January 27th, 2020, 7:40 am

Smallcap Sweep. 27-Jan-20


Nektan (NKTN) delayed accounts published and trading resumes following restructuring. Also H1 trading: B2B rev up 153%.
Safestyle UK (SFE) guides FY rev £126m up 8%. F/C is £129.5m. Order book up 24% due to sales push but extra cost of this hikes adj pretax loss to up to £1.5m. Co will spend ~£3m in 2020 on ads and improving training and systems.
Accesso Technology (ACSO) gives returning CEO 582k nil cost options LTIP with a 2 year KPI period. When did 2 years become long term?
H&T Group (HAT) guides FY pretax at the top end of market expectations.
Shield Therapeutics (STX) see FY rev £2.9m =£2.3m from milestones received from Norgine and EWO and £0.6m sales-related revenues from Norgine. F/C rev is £3.4m.
AFC Energy (AFC) invests £100k (in shares) in blue sky methane-to-hydrogen startup. Trumpets possible greener hydrogen production. If the plasma-based process looked like a winner why does it need a tinpot like AFC to fund it? Suspect will generate more headlines than hydrogen.

In line: GHE, TPG

Notes (do not rely on the data)
NKTN: Price=2.77. Cap=7m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Nektan provides international gaming solutions and services. Its products are White Label casino, Game distribution, Game studios and North America.
SFE: Price=69.19. Cap=57m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Safestyle UK manufactures and installs replacement doors and windows. Its products include double glazed doors and windows which are marketed under the EcoDiamond brand.
ACSO: Price=342. Cap=95m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
accesso Technology Group is a software company engaged in the development and application of ticketing, mobile and eCommerce technologies and virtual queuing solutions for the attractions and leisure industry.
HAT: Price=365. Cap=145m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
H&T Group is engaged in the business of pawnbroking, gold purchasing, retail of jewellery, cheque cashing, unsecured lending, Foreign Exchange and Personal Loans.
STX: Price=164. Cap=192m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Shield Therapeutics is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.
AFC: Price=19. Cap=87m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
AFC Energy develops alkaline fuel cell technology using hydrogen to produce electricity. It provides alkaline fuel cell technology in an industrial application and the technology to provide electricity in the United Kingdom.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1778
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1611 times

Re: MrC's Smallcap Sweeps for Jan 2020

#280480

Postby MrContrarian » January 28th, 2020, 7:40 am

Smallcap Sweep. 28-Jan-20
SimplyBiz lacking fizz

Next Fifteen Communications (NFC) guides FY adj profit marginally below expectations on a constant currency basis. Recovery to profitability at Beyond has taken longer than anticipated.
SimplyBiz (SBIZ) sees FY broadly in line with expectations with rev up 24% cf F/C 28%. Adj EBITDA is guided 'up', which sounds feeble.
Tribal Group (TRB) guides FY adj EBITDA marginally higher than mgmt expectations but rev slightly lower than expected.
Luceco (LUCE) sees FY adj op profit £17.5-18m, ahead of mkt expectations of £17.3m. Also guides FY20 beat.
Novacyt S.A. (NCYT) warns FY EBITDA will be down YoY as trading was impacted from Q2 by working capital constraints. Order book is significantly higher YoY.
LSL Property Services (LSL) guides FY U/L op profit slightly ahead of the Board's expectations and slightly up YoY. Outlook: "increased political stability and a favourable LSL estate agency sales pipeline...provide a positive backdrop."

In line: MAB1, SPE, DPEU, EYE, VEL, TPFG, NWF, ANX

Notes (do not rely on the data)
NFC: Price=522. Cap=452m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Next Fifteen Communications Group is a digital marketing company in the United Kingdom. It provides digital content, marketing, PR, consumer, technology, marketing software and market research services across the globe.
SBIZ: Price=234. Cap=226m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
TRB: Price=72. Cap=146m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Tribal Group is engaged in providing proprietary software products and related services to support the business needs of education, learning and training providers.
LUCE: Price=140. Cap=225m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Luceco manufactures & distributes LED lighting products, wiring accessories, portable power equipment & home entertainment products for global customer base. Its segments include LED Lighting, Wiring Accessories, Portable Power, and Ross & other.
NCYT: Price=17.96. Cap=12m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Novacyt SA develops and markets solutions in medical cytology. It offers portfolio of cancer and infectious disease diagnostics products and services. It has three reportable segment, Cytology, Diagnostics and Molecular Testing.
LSL: Price=290. Cap=302m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
LSL Property Services provides residential property services to consumers. Some of its offerings include residential sales, lettings, surveying, conveyancing and advice on mortgages and non-investment insurance products.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1778
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1611 times

Re: MrC's Smallcap Sweeps for Jan 2020

#280749

Postby MrContrarian » January 29th, 2020, 7:56 am

Smallcap Sweep. 29-Jan-20
Gattaca guts holders again

Ergomed (ERGO) guides FY rev in line, adjusted EBITDA ahead of market expectations.
Minds + Machines (MMX) FY trading: co "has experienced a fundamental improvement in topline revenue, revenue mix and cash generation in the year." Is this a beat? Surely would say so if it was. Will pay maiden FY div. Div F/C is 0.
Pendragon (PDG) FY trading: "performance improved significantly during H2, despite challenging market conditions." So a beat then? Er, no. Adj pretax around the bottom end of current expectations.
Fusion Antibodies (FAB) sees FY rev significantly ahead of market expectations but gross margin marginally below. Blames poor newer high margin service sales.
Oakley Capital Investments (OCI) end year NAV 345p/sh, up 9% (inc div) in H2 and 25% YoY. "There have been positive revaluations across the Oakley Funds, driven by continued strong performance from portfolio companies, whose average EBITDA growth was 30%."
Plutus PowerGen (PPG) H1 pretax £116k (-£132k). Confident that directors will provide further loans to keep the lights on. Will they though? "We have to be prepared for tough times ahead and your incumbent directors are determined to ensure that the Company is in a good position to take advantage of opportunities going forward."
Gattaca (GATC) slashes FY U/L pretax-cont guidance to £6m, below current market expectations of £10m. "The market has not recovered as quickly as expected and short-term growth remains uncertain, despite the decisive result in December's General Election. The timing of UK investment in major infrastructure projects is still not clear and certain manufacturing, automotive and rail sectors continue to be impacted by a lack of confidence. In addition, there is continued uncertainty surrounding IR35."
Premier Veterinary (PVG) another loan of £1.1m from a director-owned vehicle. 9% arrangement fee for a 3 month loan! Option to extend by issuing warrants. His exisiting £3.85m loan has payment and interest deferred.
GYG (GYG) sees FY comfortably ahead of previous mgmt expectations. Order book up 31%.
Polarean Imaging (POLX) positive Phase III trail results for its hyperpolarized Xenon Gas for MRI scans.
ScS Group (SCS) trading in line. CEO gives 12 months notice.
Quixant (QXT) guides rev $92.3m, adj pretax $10.7m. "The majority of the shortfall against expected revenue has been experienced in the Gaming Division."

In line: EKF, ESP, RNWH, TRMR, EMR

Notes (do not rely on the data)
ERGO: Price=436.88. Cap=209m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Ergomed is engaged in providing services to the pharmaceutical industry and develops new drugs. The Company operates in two business divisions namely Services Business and Co-Development Business.
MMX: Price=8.1. Cap=74m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Minds + Machines Group operates in the domain name industry and provides end-to-end domain services generating revenues across multiple business lines.
PDG: Price=11.56. Cap=161m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Pendragon is engaged in retailing of used and new vehicles and the service and repair of vehicles (aftersales). It operates under the brands of Stratstone for the premium vehicle segment and Evans Halshaw for the volume vehicle segment.
FAB: Price=92. Cap=20m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Fusion Antibodies is engaged in the research, development and manufacturing of recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases.
OCI: Price=265. Cap=526m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
PPG: Price=0.08. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Plutus PowerGen generates power from flexible stand-by power generation farms. The Company sells power to energy supply companies during periods of peak electricity demand or grid instability.
GATC: Price=103. Cap=33m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Gattaca is a recruitment services provider with the focus on the Engineering and Technology sector. It provides a variety of workforce solutions to various clients in the UK and internationally.
PVG: Price=53.25. Cap=8m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Premier Veterinary Group is a non-medical service provider mainly to veterinary centers. The company business operates in the veterinary industry and mainly provides support services for day to day running of veterinary centers.
GYG: Price=75.8. Cap=35m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
GYG is a superyacht painting supply and maintenance company, offering services through operations in the Mediterranean, Northern Europe and the United States.
POLX: Price=31.95. Cap=37m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
SCS: Price=235. Cap=89m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
ScS Group operates as a sofas, carpet and flooring retailer in the United Kingdom. The company focuses in fabric and leather sofas and sells an exclusive range of branded and ScS branded products.
QXT: Price=205.9. Cap=137m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Quixant and its subsidiaries are in the business of designing, manufacturing and selling of advanced PC based gaming platforms for the pay to play gaming and slot machine industry.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1778
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1611 times

Re: MrC's Smallcap Sweeps for Jan 2020

#281042

Postby MrContrarian » January 30th, 2020, 7:37 am

Smallcap Sweep. 30-Jan-20
Biome mixed

James Halstead (JHD) H1 will see 'record' profit but in line?
Anpario (ANP) guides FY rev and adj EBITDA (excluding FX) in line with market expectations. But "the increase in the value of sterling during the year has impacted the overall result as realised exchange gains have been materially outweighed by unrealised losses."
MITIE (MTO) First 9 months rev up 6% but no organic growth. Guides same for FY. Sees FY 20 and FY21 earnings in line with previous guidance.
Pebble Beach (PEB) guides FY in line with management expectations. Rev £11.2m up 22% and adj EBITDA up 25% to ~£3.5m. Net debt down £1m to £8.4m.
Belvoir Group (BLV) guides FY rev up 43% to £19.5m and so performance, including pretax, comfortably ahead of management's expectations.
Biome Technologies (BIOM) sees FY rev £7.4m down 17%. This and loss slightly better than market expectations. Expect weaker legacy RF division in this FY so co will still make FY20 EBITDA loss. CFO leaves in April. He is thanked.

In line: DSCV, AGL, SEE

Notes (do not rely on the data)
JHD: Price=564. Cap=1174m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
James Halstead manufactures and distributes flooring products. Its portfolio of brands includes Polyflor, Polysafe, Expona, Performa, Saarfloor Systems, Megastrong, Camaro, Colonia, Kudos, Expona Domestic, Voyager, Forest fx, Cavalio, and Arai.
ANP: Price=343.89. Cap=80m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Anpario produces and distributes natural feed additives for animal health, hygiene and nutrition. Its brands include Kiotechagil, Meriden and Optivite.
MTO: Price=130.7. Cap=478m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
MITIE Group is a UK-based company that primarily provides outsourcing services. It generates almost all its sales from the UK domestic market.
PEB: Price=6.26. Cap=8m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Pebble Beach Systems Group is a broadcast automation company. Its products include Marina, Marina Lite, Dolphin, Orca and Stingray.
BLV: Price=147.72. Cap=52m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Belvoir Lettings is engaged in the selling, supporting and training residential lettings franchises. It also operates letting agencies which is engaged in the collection of rent, and management of residential properties, let on behalf of landlords.
BIOM: Price=260. Cap=7m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Biome Technologies is an innovator and supplier of biodegradable natural polymers. The company operates in two segments, Bioplastics Division producing bio-degradable products and the Radio Frequency Division designing Radio Frequency furnaces.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1778
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1611 times

Re: MrC's Smallcap Sweeps for Jan 2020

#281299

Postby MrContrarian » January 31st, 2020, 7:58 am

Smallcap Sweep. 31-Jan-20
STAF & FCCN big downers

Staffline (STAF) MORE provisions and write-downs. FY adj op profit will be materially below our previous guidance.. FY20 unchanged.
GAN (GAN) sees FY rev up 115-120% and EBITDA margin ahead of market expectations.
Gulf Marine Services (GMS) rolls covenant tests again to end Feb.
French Connection (FCCN) holders' patience rewarded with a slap in the face. After an absurd 15 month attempt to sell itself it ends the process. Co will "will now focus on completing its turnaround." Will continue to cut costs, close stores, expand licencing etc. Guides FY pretax loss £1-£2m due to poor Q4.
Toople (TOOP) £1.2m placing at 0.1p, a 38% discount to buy another comms co, DMS Holding, for £1.56m (mostly in new shares at 0.1p). Also issues £1.63m of zero coupon secured Loan Notes to raise £1.24m net. Acquiree is "cash generative, accelerating Toople's timeline to achieve profitability and positive cash generation."
EQTEC (EQT) new CEO 'very pleased' progress. Lots of positive noises but no new numbers.
Open Orphan (ORPH) £5m (min) placing at 6.1p, a nil discount, "to fund the growth and synergies programme" after recent merger with hVIVO.
Billing Services Group (BILL) sells BSG Wireless business for $5.25m (£4m). Leaves the struggling Wireline Business and the stagnant TPV Business. Will return some of the cash to holders. BILL cap £3.1m.
Novacyt (NCYT) launches the research-use-only novel coronavirus test which it mentioned in finals 3 days ago.

In line: NBI, SMS

Notes (do not rely on the data)
STAF: Price=74. Cap=51m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Staffline Group PLC, together with its subsidiaries, provides recruitment and outsourced human resource service.
GAN: Price=157. Cap=134m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
GAN is a provider of online gaming software, operational support services and online game content development services to the casino industry.
GMS: Price=9. Cap=32m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Gulf Marine Services is a provider of self-propelled, self-elevating accommodation jack-up barges in the Middle East and globally. The Company's business segments are Small Class vessels, Mid-Size Class vessels, Large Class vessels, and Other vessels.
FCCN: Price=NA. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
French Connection Group is a retailer and wholesaler of fashion clothing and accessories which designs, produces and distributes branded fashion clothing for men and women.
TOOP: Price=0.16. Cap=2m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Toople provides telecommunication services in UK. The Company's services include business broadband, fibre, EFM & Ethernet data services, business mobile phones, cloud PBX and SIP Trunking and traditional services.
EQT: Price=0.17. Cap=7m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
EQTEC is a developer and operator of energy infrastructure using clean technologies. It provides Biomass Electricity and Heat sector in the United Kingdom.
ORPH: Price=6.1. Cap=27m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
BILL: Price=2. Cap=3m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Billing Services Group provides clearing and financial settlement products, Wi-Fi roaming solutions to mobile carriers and network operators and third-party verification services to the telecommunications, cable & utilities industries.
NCYT: Price=20. Cap=18m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Novacyt SA develops and markets solutions in medical cytology. It offers portfolio of cancer and infectious disease diagnostics products and services. It has three reportable segment, Cytology, Diagnostics and Molecular Testing.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

PinkDalek
Lemon Half
Posts: 6139
Joined: November 4th, 2016, 1:12 pm
Has thanked: 1589 times
Been thanked: 1801 times

Re: MrC's Smallcap Sweeps for Jan 2020

#281393

Postby PinkDalek » January 31st, 2020, 1:52 pm

MrContrarian wrote:Smallcap Sweep. 07-Jan-20
Handbrake stuck at Aston Martin


Now see viewtopic.php?p=281387#p281387 at Company Share news (LSE Main Market).


Return to “Stocks and Share Dealing Discussions”

Who is online

Users browsing this forum: No registered users and 36 guests